5th Feb 2019 17:30
LONDON (Alliance News) - Deltex Medical Group PLC said Chair Nigel Keen bought 8.7 million shares in the medical technology firm for 1.125 pence each on Tuesday.
Following the GBP97,875 deal, Keen's beneficial holding in Deltex is 62.9 million shares or 13% of the company's issued share capital.
On February 5, Deltex said its 2018 revenue is expected to be "slightly behind" expectations at GBP5.0 million. This is compared to GBP5.9 million the year prior. The full year pre-exceptional loss, however, is expected to be "broadly in line" with market expectations.
Deltex now expects to be earnings before interest, taxes, depreciation and amortisation positive in 2019 based on its new cost saving strategy.
Shares in Deltex closed up 3.6% at 1.16p on Tuesday.
Related Shares:
Deltex Medical